Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Authors' Comments

"Thanks very much for your kind work and consideration in publication of our paper. On behalf of my co-authors, we would like to express our great appreciation to the editor and reviewers. Working with you has been a wonderful journey. I and my workmates really appreciate your work and I 'll introduce the journal to others as much as I can."

Bo-Shen Gong
(Administration Office for Undergraduates, Second Military Medical University, Shanghai, 200433, China)

""I would like to express my sincere thanks for the services by Bentham Science.

I'm really happy with my submission in your Journal and hope that I will able to continue submitting manuscripts to your journal""

Saeed Samarghandian
(Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran)

"In terms of “Current Cancer Drug Targets”, the editor-in-chief and the senior manager have done high quality professional job for this journal. I am happy to work with them.

Thank you very much, Best regards."

Dr. Erxi Wu
(Department of Pharmaceutical Sciences, Fargo, USA)

"I thank you for your help in the publication of our review article in Current Cancer Drug Targets.

Mostly, I am satisfied with your service and help in publication."

Prof. Dr. Kazuhiko Ino
(Professor and Chairman Department of Obstetrics and Gynecology, Kimiidera, Wakayama, Japan)


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog